Global Medications for Prurigo Nodularis Supply, Demand and Key Producers, 2023-2029
Page: 111
Published Date: 19 Jan 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags
Description
The global Medications for Prurigo Nodularis market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Prurigo nodularis is a type of disease associated to the skin which causes itchy lumps on the skin. The itching turns to be so serious that it leads to scratches and bleeding, mainly categorized as the rare disease. The treatment for these rare disease is termed as prurigo nodularis treatment. It can get adverse when comes in contact with clothes and the common symptom associated with this disease is itchy nodules on the skin. It can be found on outer arms, legs and shoulders.
This report studies the global Medications for Prurigo Nodularis production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Medications for Prurigo Nodularis, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medications for Prurigo Nodularis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Medications for Prurigo Nodularis total production and demand, 2018-2029, (K Units)
Global Medications for Prurigo Nodularis total production value, 2018-2029, (USD Million)
Global Medications for Prurigo Nodularis production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Medications for Prurigo Nodularis consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Medications for Prurigo Nodularis domestic production, consumption, key domestic manufacturers and share
Global Medications for Prurigo Nodularis production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Medications for Prurigo Nodularis production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Medications for Prurigo Nodularis production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Medications for Prurigo Nodularis market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson Services, Inc, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Hikma Pharmaceuticals PLC, Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co., Inc, Sanofi and GSK plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medications for Prurigo Nodularis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Medications for Prurigo Nodularis Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Medications for Prurigo Nodularis Market, Segmentation by Type
Antihistamines
Capsaicin Cream
Corticosteroids
Emollients
Other
Global Medications for Prurigo Nodularis Market, Segmentation by Application
Hospitals
Specialty Clinics
Homecare
Other
Companies Profiled:
Johnson & Johnson Services, Inc
Teva Pharmaceutical Industries Ltd
Pfizer Inc
Hikma Pharmaceuticals PLC
Takeda Pharmaceutical Company Limited
Bayer AG
Merck & Co., Inc
Sanofi
GSK plc
BRISTOL-MYERS SQUIBB COMPANY
GALDERMA LABORATORIES, L.P
Mayne Pharma Group Limited
VYNE Therapeutics Inc
Trevi Therapeutics
Key Questions Answered
1. How big is the global Medications for Prurigo Nodularis market?
2. What is the demand of the global Medications for Prurigo Nodularis market?
3. What is the year over year growth of the global Medications for Prurigo Nodularis market?
4. What is the production and production value of the global Medications for Prurigo Nodularis market?
5. Who are the key producers in the global Medications for Prurigo Nodularis market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Medications for Prurigo Nodularis Introduction
1.2 World Medications for Prurigo Nodularis Supply & Forecast
1.2.1 World Medications for Prurigo Nodularis Production Value (2018 & 2022 & 2029)
1.2.2 World Medications for Prurigo Nodularis Production (2018-2029)
1.2.3 World Medications for Prurigo Nodularis Pricing Trends (2018-2029)
1.3 World Medications for Prurigo Nodularis Production by Region (Based on Production Site)
1.3.1 World Medications for Prurigo Nodularis Production Value by Region (2018-2029)
1.3.2 World Medications for Prurigo Nodularis Production by Region (2018-2029)
1.3.3 World Medications for Prurigo Nodularis Average Price by Region (2018-2029)
1.3.4 North America Medications for Prurigo Nodularis Production (2018-2029)
1.3.5 Europe Medications for Prurigo Nodularis Production (2018-2029)
1.3.6 China Medications for Prurigo Nodularis Production (2018-2029)
1.3.7 Japan Medications for Prurigo Nodularis Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medications for Prurigo Nodularis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medications for Prurigo Nodularis Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World Medications for Prurigo Nodularis Demand (2018-2029)
2.2 World Medications for Prurigo Nodularis Consumption by Region
2.2.1 World Medications for Prurigo Nodularis Consumption by Region (2018-2023)
2.2.2 World Medications for Prurigo Nodularis Consumption Forecast by Region (2024-2029)
2.3 United States Medications for Prurigo Nodularis Consumption (2018-2029)
2.4 China Medications for Prurigo Nodularis Consumption (2018-2029)
2.5 Europe Medications for Prurigo Nodularis Consumption (2018-2029)
2.6 Japan Medications for Prurigo Nodularis Consumption (2018-2029)
2.7 South Korea Medications for Prurigo Nodularis Consumption (2018-2029)
2.8 ASEAN Medications for Prurigo Nodularis Consumption (2018-2029)
2.9 India Medications for Prurigo Nodularis Consumption (2018-2029)
3.1 World Medications for Prurigo Nodularis Production Value by Manufacturer (2018-2023)
3.2 World Medications for Prurigo Nodularis Production by Manufacturer (2018-2023)
3.3 World Medications for Prurigo Nodularis Average Price by Manufacturer (2018-2023)
3.4 Medications for Prurigo Nodularis Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Medications for Prurigo Nodularis Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Medications for Prurigo Nodularis in 2022
3.5.3 Global Concentration Ratios (CR8) for Medications for Prurigo Nodularis in 2022
3.6 Medications for Prurigo Nodularis Market: Overall Company Footprint Analysis
3.6.1 Medications for Prurigo Nodularis Market: Region Footprint
3.6.2 Medications for Prurigo Nodularis Market: Company Product Type Footprint
3.6.3 Medications for Prurigo Nodularis Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Medications for Prurigo Nodularis Production Value Comparison
4.1.1 United States VS China: Medications for Prurigo Nodularis Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Medications for Prurigo Nodularis Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Medications for Prurigo Nodularis Production Comparison
4.2.1 United States VS China: Medications for Prurigo Nodularis Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Medications for Prurigo Nodularis Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Medications for Prurigo Nodularis Consumption Comparison
4.3.1 United States VS China: Medications for Prurigo Nodularis Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Medications for Prurigo Nodularis Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Medications for Prurigo Nodularis Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Medications for Prurigo Nodularis Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Medications for Prurigo Nodularis Production Value (2018-2023)
4.4.3 United States Based Manufacturers Medications for Prurigo Nodularis Production (2018-2023)
4.5 China Based Medications for Prurigo Nodularis Manufacturers and Market Share
4.5.1 China Based Medications for Prurigo Nodularis Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Medications for Prurigo Nodularis Production Value (2018-2023)
4.5.3 China Based Manufacturers Medications for Prurigo Nodularis Production (2018-2023)
4.6 Rest of World Based Medications for Prurigo Nodularis Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Medications for Prurigo Nodularis Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Medications for Prurigo Nodularis Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Medications for Prurigo Nodularis Production (2018-2023)
5.1 World Medications for Prurigo Nodularis Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antihistamines
5.2.2 Capsaicin Cream
5.2.3 Corticosteroids
5.2.4 Emollients
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Medications for Prurigo Nodularis Production by Type (2018-2029)
5.3.2 World Medications for Prurigo Nodularis Production Value by Type (2018-2029)
5.3.3 World Medications for Prurigo Nodularis Average Price by Type (2018-2029)
6.1 World Medications for Prurigo Nodularis Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.2.3 Homecare
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Medications for Prurigo Nodularis Production by Application (2018-2029)
6.3.2 World Medications for Prurigo Nodularis Production Value by Application (2018-2029)
6.3.3 World Medications for Prurigo Nodularis Average Price by Application (2018-2029)
7.1 Johnson & Johnson Services, Inc
7.1.1 Johnson & Johnson Services, Inc Details
7.1.2 Johnson & Johnson Services, Inc Major Business
7.1.3 Johnson & Johnson Services, Inc Medications for Prurigo Nodularis Product and Services
7.1.4 Johnson & Johnson Services, Inc Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Johnson & Johnson Services, Inc Recent Developments/Updates
7.1.6 Johnson & Johnson Services, Inc Competitive Strengths & Weaknesses
7.2 Teva Pharmaceutical Industries Ltd
7.2.1 Teva Pharmaceutical Industries Ltd Details
7.2.2 Teva Pharmaceutical Industries Ltd Major Business
7.2.3 Teva Pharmaceutical Industries Ltd Medications for Prurigo Nodularis Product and Services
7.2.4 Teva Pharmaceutical Industries Ltd Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.2.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.3 Pfizer Inc
7.3.1 Pfizer Inc Details
7.3.2 Pfizer Inc Major Business
7.3.3 Pfizer Inc Medications for Prurigo Nodularis Product and Services
7.3.4 Pfizer Inc Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Inc Recent Developments/Updates
7.3.6 Pfizer Inc Competitive Strengths & Weaknesses
7.4 Hikma Pharmaceuticals PLC
7.4.1 Hikma Pharmaceuticals PLC Details
7.4.2 Hikma Pharmaceuticals PLC Major Business
7.4.3 Hikma Pharmaceuticals PLC Medications for Prurigo Nodularis Product and Services
7.4.4 Hikma Pharmaceuticals PLC Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
7.4.6 Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
7.5 Takeda Pharmaceutical Company Limited
7.5.1 Takeda Pharmaceutical Company Limited Details
7.5.2 Takeda Pharmaceutical Company Limited Major Business
7.5.3 Takeda Pharmaceutical Company Limited Medications for Prurigo Nodularis Product and Services
7.5.4 Takeda Pharmaceutical Company Limited Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.5.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.6 Bayer AG
7.6.1 Bayer AG Details
7.6.2 Bayer AG Major Business
7.6.3 Bayer AG Medications for Prurigo Nodularis Product and Services
7.6.4 Bayer AG Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bayer AG Recent Developments/Updates
7.6.6 Bayer AG Competitive Strengths & Weaknesses
7.7 Merck & Co., Inc
7.7.1 Merck & Co., Inc Details
7.7.2 Merck & Co., Inc Major Business
7.7.3 Merck & Co., Inc Medications for Prurigo Nodularis Product and Services
7.7.4 Merck & Co., Inc Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck & Co., Inc Recent Developments/Updates
7.7.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.8 Sanofi
7.8.1 Sanofi Details
7.8.2 Sanofi Major Business
7.8.3 Sanofi Medications for Prurigo Nodularis Product and Services
7.8.4 Sanofi Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sanofi Recent Developments/Updates
7.8.6 Sanofi Competitive Strengths & Weaknesses
7.9 GSK plc
7.9.1 GSK plc Details
7.9.2 GSK plc Major Business
7.9.3 GSK plc Medications for Prurigo Nodularis Product and Services
7.9.4 GSK plc Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 GSK plc Recent Developments/Updates
7.9.6 GSK plc Competitive Strengths & Weaknesses
7.10 BRISTOL-MYERS SQUIBB COMPANY
7.10.1 BRISTOL-MYERS SQUIBB COMPANY Details
7.10.2 BRISTOL-MYERS SQUIBB COMPANY Major Business
7.10.3 BRISTOL-MYERS SQUIBB COMPANY Medications for Prurigo Nodularis Product and Services
7.10.4 BRISTOL-MYERS SQUIBB COMPANY Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 BRISTOL-MYERS SQUIBB COMPANY Recent Developments/Updates
7.10.6 BRISTOL-MYERS SQUIBB COMPANY Competitive Strengths & Weaknesses
7.11 GALDERMA LABORATORIES, L.P
7.11.1 GALDERMA LABORATORIES, L.P Details
7.11.2 GALDERMA LABORATORIES, L.P Major Business
7.11.3 GALDERMA LABORATORIES, L.P Medications for Prurigo Nodularis Product and Services
7.11.4 GALDERMA LABORATORIES, L.P Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 GALDERMA LABORATORIES, L.P Recent Developments/Updates
7.11.6 GALDERMA LABORATORIES, L.P Competitive Strengths & Weaknesses
7.12 Mayne Pharma Group Limited
7.12.1 Mayne Pharma Group Limited Details
7.12.2 Mayne Pharma Group Limited Major Business
7.12.3 Mayne Pharma Group Limited Medications for Prurigo Nodularis Product and Services
7.12.4 Mayne Pharma Group Limited Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Mayne Pharma Group Limited Recent Developments/Updates
7.12.6 Mayne Pharma Group Limited Competitive Strengths & Weaknesses
7.13 VYNE Therapeutics Inc
7.13.1 VYNE Therapeutics Inc Details
7.13.2 VYNE Therapeutics Inc Major Business
7.13.3 VYNE Therapeutics Inc Medications for Prurigo Nodularis Product and Services
7.13.4 VYNE Therapeutics Inc Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 VYNE Therapeutics Inc Recent Developments/Updates
7.13.6 VYNE Therapeutics Inc Competitive Strengths & Weaknesses
7.14 Trevi Therapeutics
7.14.1 Trevi Therapeutics Details
7.14.2 Trevi Therapeutics Major Business
7.14.3 Trevi Therapeutics Medications for Prurigo Nodularis Product and Services
7.14.4 Trevi Therapeutics Medications for Prurigo Nodularis Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Trevi Therapeutics Recent Developments/Updates
7.14.6 Trevi Therapeutics Competitive Strengths & Weaknesses
8.1 Medications for Prurigo Nodularis Industry Chain
8.2 Medications for Prurigo Nodularis Upstream Analysis
8.2.1 Medications for Prurigo Nodularis Core Raw Materials
8.2.2 Main Manufacturers of Medications for Prurigo Nodularis Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Medications for Prurigo Nodularis Production Mode
8.6 Medications for Prurigo Nodularis Procurement Model
8.7 Medications for Prurigo Nodularis Industry Sales Model and Sales Channels
8.7.1 Medications for Prurigo Nodularis Sales Model
8.7.2 Medications for Prurigo Nodularis Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Medications for Prurigo Nodularis Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Medications for Prurigo Nodularis Production Value by Region (2018-2023) & (USD Million)
Table 3. World Medications for Prurigo Nodularis Production Value by Region (2024-2029) & (USD Million)
Table 4. World Medications for Prurigo Nodularis Production Value Market Share by Region (2018-2023)
Table 5. World Medications for Prurigo Nodularis Production Value Market Share by Region (2024-2029)
Table 6. World Medications for Prurigo Nodularis Production by Region (2018-2023) & (K Units)
Table 7. World Medications for Prurigo Nodularis Production by Region (2024-2029) & (K Units)
Table 8. World Medications for Prurigo Nodularis Production Market Share by Region (2018-2023)
Table 9. World Medications for Prurigo Nodularis Production Market Share by Region (2024-2029)
Table 10. World Medications for Prurigo Nodularis Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Medications for Prurigo Nodularis Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Medications for Prurigo Nodularis Major Market Trends
Table 13. World Medications for Prurigo Nodularis Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Medications for Prurigo Nodularis Consumption by Region (2018-2023) & (K Units)
Table 15. World Medications for Prurigo Nodularis Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Medications for Prurigo Nodularis Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Medications for Prurigo Nodularis Producers in 2022
Table 18. World Medications for Prurigo Nodularis Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Medications for Prurigo Nodularis Producers in 2022
Table 20. World Medications for Prurigo Nodularis Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Medications for Prurigo Nodularis Company Evaluation Quadrant
Table 22. World Medications for Prurigo Nodularis Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Medications for Prurigo Nodularis Production Site of Key Manufacturer
Table 24. Medications for Prurigo Nodularis Market: Company Product Type Footprint
Table 25. Medications for Prurigo Nodularis Market: Company Product Application Footprint
Table 26. Medications for Prurigo Nodularis Competitive Factors
Table 27. Medications for Prurigo Nodularis New Entrant and Capacity Expansion Plans
Table 28. Medications for Prurigo Nodularis Mergers & Acquisitions Activity
Table 29. United States VS China Medications for Prurigo Nodularis Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Medications for Prurigo Nodularis Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Medications for Prurigo Nodularis Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Medications for Prurigo Nodularis Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Medications for Prurigo Nodularis Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Medications for Prurigo Nodularis Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Medications for Prurigo Nodularis Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Medications for Prurigo Nodularis Production Market Share (2018-2023)
Table 37. China Based Medications for Prurigo Nodularis Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Medications for Prurigo Nodularis Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Medications for Prurigo Nodularis Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Medications for Prurigo Nodularis Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Medications for Prurigo Nodularis Production Market Share (2018-2023)
Table 42. Rest of World Based Medications for Prurigo Nodularis Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Medications for Prurigo Nodularis Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Medications for Prurigo Nodularis Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Medications for Prurigo Nodularis Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Medications for Prurigo Nodularis Production Market Share (2018-2023)
Table 47. World Medications for Prurigo Nodularis Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Medications for Prurigo Nodularis Production by Type (2018-2023) & (K Units)
Table 49. World Medications for Prurigo Nodularis Production by Type (2024-2029) & (K Units)
Table 50. World Medications for Prurigo Nodularis Production Value by Type (2018-2023) & (USD Million)
Table 51. World Medications for Prurigo Nodularis Production Value by Type (2024-2029) & (USD Million)
Table 52. World Medications for Prurigo Nodularis Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Medications for Prurigo Nodularis Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Medications for Prurigo Nodularis Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Medications for Prurigo Nodularis Production by Application (2018-2023) & (K Units)
Table 56. World Medications for Prurigo Nodularis Production by Application (2024-2029) & (K Units)
Table 57. World Medications for Prurigo Nodularis Production Value by Application (2018-2023) & (USD Million)
Table 58. World Medications for Prurigo Nodularis Production Value by Application (2024-2029) & (USD Million)
Table 59. World Medications for Prurigo Nodularis Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Medications for Prurigo Nodularis Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Johnson & Johnson Services, Inc Basic Information, Manufacturing Base and Competitors
Table 62. Johnson & Johnson Services, Inc Major Business
Table 63. Johnson & Johnson Services, Inc Medications for Prurigo Nodularis Product and Services
Table 64. Johnson & Johnson Services, Inc Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Johnson & Johnson Services, Inc Recent Developments/Updates
Table 66. Johnson & Johnson Services, Inc Competitive Strengths & Weaknesses
Table 67. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical Industries Ltd Major Business
Table 69. Teva Pharmaceutical Industries Ltd Medications for Prurigo Nodularis Product and Services
Table 70. Teva Pharmaceutical Industries Ltd Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 72. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 73. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Inc Major Business
Table 75. Pfizer Inc Medications for Prurigo Nodularis Product and Services
Table 76. Pfizer Inc Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Inc Recent Developments/Updates
Table 78. Pfizer Inc Competitive Strengths & Weaknesses
Table 79. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 80. Hikma Pharmaceuticals PLC Major Business
Table 81. Hikma Pharmaceuticals PLC Medications for Prurigo Nodularis Product and Services
Table 82. Hikma Pharmaceuticals PLC Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 84. Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
Table 85. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Pharmaceutical Company Limited Major Business
Table 87. Takeda Pharmaceutical Company Limited Medications for Prurigo Nodularis Product and Services
Table 88. Takeda Pharmaceutical Company Limited Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 90. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 91. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 92. Bayer AG Major Business
Table 93. Bayer AG Medications for Prurigo Nodularis Product and Services
Table 94. Bayer AG Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bayer AG Recent Developments/Updates
Table 96. Bayer AG Competitive Strengths & Weaknesses
Table 97. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 98. Merck & Co., Inc Major Business
Table 99. Merck & Co., Inc Medications for Prurigo Nodularis Product and Services
Table 100. Merck & Co., Inc Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck & Co., Inc Recent Developments/Updates
Table 102. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 103. Sanofi Basic Information, Manufacturing Base and Competitors
Table 104. Sanofi Major Business
Table 105. Sanofi Medications for Prurigo Nodularis Product and Services
Table 106. Sanofi Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sanofi Recent Developments/Updates
Table 108. Sanofi Competitive Strengths & Weaknesses
Table 109. GSK plc Basic Information, Manufacturing Base and Competitors
Table 110. GSK plc Major Business
Table 111. GSK plc Medications for Prurigo Nodularis Product and Services
Table 112. GSK plc Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. GSK plc Recent Developments/Updates
Table 114. GSK plc Competitive Strengths & Weaknesses
Table 115. BRISTOL-MYERS SQUIBB COMPANY Basic Information, Manufacturing Base and Competitors
Table 116. BRISTOL-MYERS SQUIBB COMPANY Major Business
Table 117. BRISTOL-MYERS SQUIBB COMPANY Medications for Prurigo Nodularis Product and Services
Table 118. BRISTOL-MYERS SQUIBB COMPANY Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. BRISTOL-MYERS SQUIBB COMPANY Recent Developments/Updates
Table 120. BRISTOL-MYERS SQUIBB COMPANY Competitive Strengths & Weaknesses
Table 121. GALDERMA LABORATORIES, L.P Basic Information, Manufacturing Base and Competitors
Table 122. GALDERMA LABORATORIES, L.P Major Business
Table 123. GALDERMA LABORATORIES, L.P Medications for Prurigo Nodularis Product and Services
Table 124. GALDERMA LABORATORIES, L.P Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. GALDERMA LABORATORIES, L.P Recent Developments/Updates
Table 126. GALDERMA LABORATORIES, L.P Competitive Strengths & Weaknesses
Table 127. Mayne Pharma Group Limited Basic Information, Manufacturing Base and Competitors
Table 128. Mayne Pharma Group Limited Major Business
Table 129. Mayne Pharma Group Limited Medications for Prurigo Nodularis Product and Services
Table 130. Mayne Pharma Group Limited Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Mayne Pharma Group Limited Recent Developments/Updates
Table 132. Mayne Pharma Group Limited Competitive Strengths & Weaknesses
Table 133. VYNE Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 134. VYNE Therapeutics Inc Major Business
Table 135. VYNE Therapeutics Inc Medications for Prurigo Nodularis Product and Services
Table 136. VYNE Therapeutics Inc Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. VYNE Therapeutics Inc Recent Developments/Updates
Table 138. Trevi Therapeutics Basic Information, Manufacturing Base and Competitors
Table 139. Trevi Therapeutics Major Business
Table 140. Trevi Therapeutics Medications for Prurigo Nodularis Product and Services
Table 141. Trevi Therapeutics Medications for Prurigo Nodularis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Medications for Prurigo Nodularis Upstream (Raw Materials)
Table 143. Medications for Prurigo Nodularis Typical Customers
Table 144. Medications for Prurigo Nodularis Typical Distributors
List of Figure
Figure 1. Medications for Prurigo Nodularis Picture
Figure 2. World Medications for Prurigo Nodularis Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Medications for Prurigo Nodularis Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Medications for Prurigo Nodularis Production (2018-2029) & (K Units)
Figure 5. World Medications for Prurigo Nodularis Average Price (2018-2029) & (US$/Unit)
Figure 6. World Medications for Prurigo Nodularis Production Value Market Share by Region (2018-2029)
Figure 7. World Medications for Prurigo Nodularis Production Market Share by Region (2018-2029)
Figure 8. North America Medications for Prurigo Nodularis Production (2018-2029) & (K Units)
Figure 9. Europe Medications for Prurigo Nodularis Production (2018-2029) & (K Units)
Figure 10. China Medications for Prurigo Nodularis Production (2018-2029) & (K Units)
Figure 11. Japan Medications for Prurigo Nodularis Production (2018-2029) & (K Units)
Figure 12. Medications for Prurigo Nodularis Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Medications for Prurigo Nodularis Consumption (2018-2029) & (K Units)
Figure 15. World Medications for Prurigo Nodularis Consumption Market Share by Region (2018-2029)
Figure 16. United States Medications for Prurigo Nodularis Consumption (2018-2029) & (K Units)
Figure 17. China Medications for Prurigo Nodularis Consumption (2018-2029) & (K Units)
Figure 18. Europe Medications for Prurigo Nodularis Consumption (2018-2029) & (K Units)
Figure 19. Japan Medications for Prurigo Nodularis Consumption (2018-2029) & (K Units)
Figure 20. South Korea Medications for Prurigo Nodularis Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Medications for Prurigo Nodularis Consumption (2018-2029) & (K Units)
Figure 22. India Medications for Prurigo Nodularis Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Medications for Prurigo Nodularis by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Medications for Prurigo Nodularis Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Medications for Prurigo Nodularis Markets in 2022
Figure 26. United States VS China: Medications for Prurigo Nodularis Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Medications for Prurigo Nodularis Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Medications for Prurigo Nodularis Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Medications for Prurigo Nodularis Production Market Share 2022
Figure 30. China Based Manufacturers Medications for Prurigo Nodularis Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Medications for Prurigo Nodularis Production Market Share 2022
Figure 32. World Medications for Prurigo Nodularis Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Medications for Prurigo Nodularis Production Value Market Share by Type in 2022
Figure 34. Antihistamines
Figure 35. Capsaicin Cream
Figure 36. Corticosteroids
Figure 37. Emollients
Figure 38. Other
Figure 39. World Medications for Prurigo Nodularis Production Market Share by Type (2018-2029)
Figure 40. World Medications for Prurigo Nodularis Production Value Market Share by Type (2018-2029)
Figure 41. World Medications for Prurigo Nodularis Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Medications for Prurigo Nodularis Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Medications for Prurigo Nodularis Production Value Market Share by Application in 2022
Figure 44. Hospitals
Figure 45. Specialty Clinics
Figure 46. Homecare
Figure 47. Other
Figure 48. World Medications for Prurigo Nodularis Production Market Share by Application (2018-2029)
Figure 49. World Medications for Prurigo Nodularis Production Value Market Share by Application (2018-2029)
Figure 50. World Medications for Prurigo Nodularis Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Medications for Prurigo Nodularis Industry Chain
Figure 52. Medications for Prurigo Nodularis Procurement Model
Figure 53. Medications for Prurigo Nodularis Sales Model
Figure 54. Medications for Prurigo Nodularis Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Related Reports
19 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
